|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/00 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| C07K 16/28 | (2006.01) | ||
| A61K 9/00 | (2006.01) |
| (11) | Number of the document | 2170388 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08781323.4 |
| Date of filing the European patent application | 2008-07-03 | |
| (97) | Date of publication of the European application | 2010-04-07 |
| (45) | Date of publication and mention of the grant of the patent | 2016-10-12 |
| (46) | Date of publication of the claims translation | 2017-01-10 |
| (86) | Number | PCT/US2008/069125 |
| Date | 2008-07-03 |
| (87) | Number | WO 2009/009407 |
| Date | 2009-01-15 |
| (30) | Number | Date | Country code |
| 948220 P | 2007-07-06 | US |
| (72) |
BRISBANE, Charlene, E., US
KETKAR, Amol, Sharad, US
LASHMAR, Ulla, Tove, GB
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Anti-CD20 antikūno kompozicijos |
| ANTI-CD20 ANTIBODY FORMULATIONS |
| Payment date | Validity (years) | Amount | |
| 2025-06-18 | 18 | 347.00 EUR |
| 2026-07-03 |